min(3.0 ml/ min) for 6 minutes, respectively, on different occasions. At the end of the infusions average increases in blood pressure were 20/22 mmHg(p< 0.001) and 6/7 mmHg(p<0.001), respectively, with the former 2 peptides, while the last peptide showed no pressor action at all. It had previously been found by our research group that angiotensin III, angiotensin II-(3-8)-hexapeptide, angiotensin II-(4-8)-pentapeptide, angiotensin II-(2-7)-hexapeptide, angiotensin II-(1-7)-heptapeptide and angiotensin II-(1-6)-hexapeptide have some pressor action but that angiotensin II-(5-8)-tetrapptide has no pressor action in normal men. When these previous results are combined with the present result, it is evident that only tyrosine-containing molecules show pressor activity and that tyrosine-deleted molecules do not show pressor activity at all. It is concluded that tyrosine in position 4 is the key amino acid for the binding of angiotensin II to human arteriolar receptor.
min(3.0 ml/ min) for 6 minutes, respectively, on different occasions. At the end of the infusions average increases in blood pressure were 20/22 mmHg(p< 0.001) and 6/7 mmHg(p<0.001), respectively, with the former 2 peptides, while the last peptide showed no pressor action at all. It had previously been found by our research group that angiotensin III, angiotensin II-(3-8)-hexapeptide, angiotensin II-(4-8)-pentapeptide, angiotensin II-(2-7)-hexapeptide, angiotensin II-(1-7)-heptapeptide and angiotensin II-(1-6)-hexapeptide have some pressor action but that angiotensin II-(5-8)-tetrapptide has no pressor action in normal men. When these previous results are combined with the present result, it is evident that only tyrosine-containing molecules show pressor activity and that tyrosine-deleted molecules do not show pressor activity at all. It is concluded that tyrosine in position 4 is the key amino acid for the binding of angiotensin II to human arteriolar receptor. (Kono et al., 1975; Kono et al., 1978; Kono et al., 1982; Kono et al., 1983; Kono et al., 1985a; Kono et al., 1985b; Kono et al., 1985d; Kono et al., 1986) . This time large amounts of ANG
and ANG II-(1-3)-tripeptide[ANG II-(1-3)]were given to normal men mainly for their pressor action.
Materials and Methods
Five normal men were examined in the present study. Their ages were 26 to 35 years, and their body weights were 52 to 55 kg. Consent was obtained from each subject for the experiment. In Experiment 1 plasma renin activity(PRA) and plasma aldosterone(PA) were determined before and at the end of the infusion of ANG-(1-5). The radioimmunoassay methods for PRA and PA were described previously (Kono et al., 1975; Kono et al., 1980) . Statistical analysis of the experimental data was done by analysis of variance (Wallenstein et al., 1980) 
Discussion
It had been reported that there is a specific receptor for angiotensin III(ANG III) in rat adrenals (Devynck et al., 1977) , and it had been assumed that ANG III might have arteriolar and adrenal receptors which are different from those for ANG II in man (Carey et al., 1978a; cently concluded that ANG II (Kono et al., 1975; Kono et al., 1978; 1985b; Kono et al., 1985c) , ANG III (Kono et al., 1975; Kono et al., 1978; Kono et al., 1985a) It was also assumed that steroidogenic ANG II fragments might have the same adrenocortical receptor in man (Kono et al., 1985a) . From this standpoint we undertook further studies on the biological activities of hitherto untested ANG II fragments-ANG-(1-5), ANG-(1-4) and ANG-(1-3) in normal men. (Kono et al., 1975 (Kono et al., -1986 From these results it is concluded that tyrosine in position 4 in the ANG II molecule is the key amino acid for the binding to human arteriolar ANG II receptor.
It was reported that alanine4-ANG II showed no pressor activity in the rat (Peach et al., 1969) . This indicates the importance of the presence of tyrosine in position 4 for pressor action. Our conclusions do not conflict with this report.
For the direct renin-suppressing action, it is thought at present from this table that However, as some position 8-substituted ANG II analogues are more or less steroidogenic (Kono et al., 1976; Kono et al., 1985c) , valine in position 3 is thought to be more important. Fig. 3 is a putative schema of the binding of ANG II to the human arteriolar ANG II receptor. Tyrosine is probably the binding portion, and there are 2 acting portions namely, Asp-Arg-Val-Tyr on Nterminal side and Tyr-Ile-His-Pro-Phe on the C-terminal side. The latter is more active than the former (Kono et al., 1983) . Arteriolar ANG II receptor probably recognizes these 2 acting molecules. It is thought that both molecules co-operate to reinforce the pressor activity and especially, as reported previously (Kono et al., 1975; Kono et al., 1978; Kono et al., 1982; Kono et al., 1986) , aspartic acid in position 1, arginine in position 2 and phenylalanine in position 8 contribute to a great extent to the enhancement of the pressor action of the ANG II molecule.
